These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 17312292)
1. Molecular diagnostics of hepatitis C virus infection: a systematic review. Scott JD; Gretch DR JAMA; 2007 Feb; 297(7):724-32. PubMed ID: 17312292 [TBL] [Abstract][Full Text] [Related]
2. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714 [TBL] [Abstract][Full Text] [Related]
3. Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay. Ferraro D; Giglio M; Bonura C; Di Marco V; Mondelli MU; Craxì A; Di Stefano R J Viral Hepat; 2008 Jan; 15(1):66-70. PubMed ID: 18088247 [TBL] [Abstract][Full Text] [Related]
4. Molecular testing in the diagnosis and management of hepatitis C virus infection. Podzorski RP Arch Pathol Lab Med; 2002 Mar; 126(3):285-90. PubMed ID: 11860301 [TBL] [Abstract][Full Text] [Related]
5. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585 [TBL] [Abstract][Full Text] [Related]
6. Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test. Kanda T; Imazeki F; Yonemitsu Y; Mikami S; Takada N; Nishino T; Takashi M; Tsubota A; Kato K; Sugiura N; Tawada A; Wu S; Tanaka T; Nakamoto S; Mikata R; Tada M; Chiba T; Kurihara T; Arai M; Fujiwara K; Kanai F; Yokosuka O J Viral Hepat; 2011 Jul; 18(7):e292-7. PubMed ID: 21129130 [TBL] [Abstract][Full Text] [Related]
7. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP; N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics. Pawlotsky JM Semin Liver Dis; 2003; 23 Suppl 1():3-11. PubMed ID: 12934162 [TBL] [Abstract][Full Text] [Related]
9. Laboratory approaches to the diagnosis of hepatitis C virus infection. Jerome KR; Gretch DR Minerva Gastroenterol Dietol; 2004 Mar; 50(1):9-20. PubMed ID: 15719002 [TBL] [Abstract][Full Text] [Related]
10. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment. Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL; Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795 [TBL] [Abstract][Full Text] [Related]
11. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors. Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764 [TBL] [Abstract][Full Text] [Related]
12. Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring. Soulier A; Poiteau L; Rosa I; Hézode C; Roudot-Thoraval F; Pawlotsky JM; Chevaliez S J Infect Dis; 2016 Apr; 213(7):1087-95. PubMed ID: 26333945 [TBL] [Abstract][Full Text] [Related]
13. COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification. Deeks ED Mol Diagn Ther; 2015 Feb; 19(1):1-7. PubMed ID: 25351623 [TBL] [Abstract][Full Text] [Related]
14. Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection. Cho YK; Kim YN; Song BC Clin Mol Hepatol; 2014 Dec; 20(4):368-75. PubMed ID: 25548743 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus diagnostics: technology, clinical applications and impacts. Conry-Cantilena C Trends Biotechnol; 1997 Feb; 15(2):71-6. PubMed ID: 9081301 [TBL] [Abstract][Full Text] [Related]
16. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy]. Takenokuchi M; Yasuda C; Nakamachi Y; Mukai M; Yoon S; Kondoh S; Kumagai S Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019 [TBL] [Abstract][Full Text] [Related]
17. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications. Al Olaby RR; Azzazy HM Expert Rev Mol Diagn; 2011 Jan; 11(1):53-64. PubMed ID: 21171921 [TBL] [Abstract][Full Text] [Related]
19. Virological tools for optimal management of chronic hepatitis C. Deltenre P Acta Gastroenterol Belg; 2009; 72(4):421-4. PubMed ID: 20163036 [TBL] [Abstract][Full Text] [Related]
20. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections. Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]